Racura Oncology LtdASX: RAC

Racura Presents CPACS Data at GCOS 2026

Oct 6, 2026 at 5:54 PM EDT · Issued by Racura Oncology Ltd via ASX

Filed with ASX · Oct 6, 2026 at 5:54 PM EDT

On 6ix: 6ix.com/news/racura-presents-cpacs-data-at-gcos-2026

Racura Oncology Ltd | ABN 61 149 318 749 | L36 1 Macquarie Place Sydney NSW 2000 Australia +61 2 8051 3043 | [email protected] | www.racuraoncology.com 1 ASX Announcement Racura Presents CPACS Phase 1 RC220 and Doxorubicin Data at the 2026 Global Cardio-Oncology Summit § Poster presented at...

View Attachment

6ix hasn’t read this filing yet.

Racura Oncology Ltd on 6ix

Earlier from Racura Oncology

Date of AGM & Closing Date for Director NominationsOct 4
Appendix 3Y - Dr Daniel TillettSep 29
RC220 MYC-silencing data to be presented FCS 26 conferenceSep 7
Racura Oncology Adelaide Investor BriefingSep 3
Notification regarding unquoted securities - RACAug 31

Later from Racura Oncology

HARNESS-1 First Cohort ClearedOct 11
Sept 2026 Quarterly Activities Report and Appendix 4COct 21
Letter to Shareholders, Notice of AGM & Proxy FormOct 21

All Racura Oncology news releases

Follow Racura Oncology into a list and get an email when it puts out news.

Follow Racura Oncology